Clinical Cancer Research Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, E.
Right arrow Articles by Shimada, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, E.
Right arrow Articles by Shimada, Y.
Clinical Cancer Research Vol. 11, 1827-1834, March 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

The Clinical Significance of Aurora-A/STK15/BTAK Expression in Human Esophageal Squamous Cell Carcinoma

Eiji Tanaka1, Yosuke Hashimoto1, Tetsuo Ito1, Tomoyuki Okumura1, Takatsugu Kan1, Go Watanabe1, Masayuki Imamura2, Johji Inazawa3 and Yutaka Shimada1

1 Department of Surgery and Surgical Basic Science, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 2 Department of Surgery Saiseikai Noe Hospital, Osaka, Japan; and3 Department of Molecular Cytogenetics, Graduate School of Biomedical Science, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan

Requests for reprints: Yutaka Shimada, Department of Surgery and Surgical Basic Science, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawara-Cho, Sakyo-Ku, Kyoto, 606-8507, Japan. Phone: 81-75-751-3626; Fax: 81-75-751-4390; E-mail: shimada{at}kuhp.kyoto-u.ac.jp.

Purpose: Aurora-A/STK15/BTAK (Aurora-A) encodes a Serine/Threonine kinase associated with chromosomal distribution, and its up-regulation induces chromosomal instability thereby leading to aneuploidy and cell transformation in several types of cancer. In this study, we investigated the role of Aurora-A in human esophageal squamous cell carcinoma (ESCC).

Experimental Design: The expression levels of Aurora-A mRNA were compared in 33 ESCC tissues with that in corresponding normal esophageal epithelium by semiquantitative reverse transcription-PCR, and the distribution patterns and expression levels of Aurora-A protein were immunohistochemically investigated in the ESCC tumors of 142 patients. The results were then separately compared with the clinicopathologic findings of the patients, and the expression of Aurora-A was examined in nine ESCC cell lines and a normal esophageal epithelial cell line using Western blot analysis.

Results: The up-regulation of Aurora-A mRNA was found in 30% (10 of 33) of the tumors by semiquantitative reverse transcription-PCR, and protein up-regulation was found in 53% (75 of 142) of the patients by immunohistochemistry. mRNA and protein up-regulation of Aurora-A were correlated with distant lymph node metastasis (P = 0.05 and P = 0.04, respectively), and patients with Aurora-A mRNA or protein up-regulation had a poorer prognosis (P = 0.003 and P = 0.0009, respectively). Furthermore, multivariate analysis revealed that up-regulation of the Aurora-A protein was an independent prognostic factor. In addition, Aurora-A expression in all ESCC cell lines was higher than that in a normal esophageal epithelial cell line.

Conclusions: The up-regulation of Aurora-A expression may reflect the malignant behavior of ESCC and may prove useful information as a prognostic factor for ESCC patients.

Key Words: Distant lymph node metastasis • Immunohistochemistry • Prognostic factor




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
E. Ogawa, K. Takenaka, H. Katakura, M. Adachi, Y. Otake, Y. Toda, H. Kotani, T. Manabe, H. Wada, and F. Tanaka
Perimembrane Aurora-A Expression is a Significant Prognostic Factor in Correlation with Proliferative Activity in Non-Small-Cell Lung Cancer (NSCLC)
Ann. Surg. Oncol., February 1, 2008; 15(2): 547 - 554.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Guan, X.-r. Wang, X.-f. Zhu, X.-f. Huang, J. Xu, L.-h. Wang, X.-b. Wan, Z.-j. Long, J.-n. Liu, G.-k. Feng, et al.
Aurora-A, a Negative Prognostic Marker, Increases Migration and Decreases Radiosensitivity in Cancer Cells
Cancer Res., November 1, 2007; 67(21): 10436 - 10444.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Lassmann, Y. Shen, U. Jutting, P. Wiehle, A. Walch, G. Gitsch, A. Hasenburg, and M. Werner
Predictive Value of Aurora-A/STK15 Expression for Late Stage Epithelial Ovarian Cancer Patients Treated by Adjuvant Chemotherapy
Clin. Cancer Res., July 15, 2007; 13(14): 4083 - 4091.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. N. Landen Jr., Y. G. Lin, A. Immaneni, M. T. Deavers, W. M. Merritt, W. A. Spannuth, D. C. Bodurka, D. M. Gershenson, W. R. Brinkley, and A. K. Sood
Overexpression of the Centrosomal Protein Aurora-A Kinase is Associated with Poor Prognosis in Epithelial Ovarian Cancer Patients
Clin. Cancer Res., July 15, 2007; 13(14): 4098 - 4104.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
E. Burum-Auensen, P. M. De Angelis, A. R. Schjolberg, K. L. Kravik, M. Aure, and O. P. F. Clausen
Subcellular Localization of the Spindle Proteins Aurora A, Mad2, and BUBR1 Assessed by Immunohistochemistry
J. Histochem. Cytochem., May 1, 2007; 55(5): 477 - 486.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Tanaka, Y. Hashimoto, T. Ito, K. Kondo, M. Higashiyama, S. Tsunoda, C. Ortiz, Y. Sakai, J. Inazawa, and Y. Shimada
The Suppression of Aurora-A/STK15/BTAK Expression Enhances Chemosensitivity to Docetaxel in Human Esophageal Squamous Cell Carcinoma
Clin. Cancer Res., February 15, 2007; 13(4): 1331 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
B. Vischioni, J. J. Oudejans, W. Vos, J. A. Rodriguez, and G. Giaccone
Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients.
Mol. Cancer Ther., November 1, 2006; 5(11): 2905 - 2913.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Reiter, P. Gais, U. Jutting, M. K. Steuer-Vogt, A. Pickhard, K. Bink, S. Rauser, S. Lassmann, H. Hofler, M. Werner, et al.
Aurora Kinase A Messenger RNA Overexpression Is Correlated with Tumor Progression and Shortened Survival in Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res., September 1, 2006; 12(17): 5136 - 5141.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
C.-X. Deng
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution
Nucleic Acids Res., March 6, 2006; 34(5): 1416 - 1426.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Ito, Y. Hashimoto, E. Tanaka, T. Kan, S. Tsunoda, F. Sato, M. Higashiyama, T. Okumura, and Y. Shimada
An Inducible Short-Hairpin RNA Vector against Osteopontin Reduces Metastatic Potential of Human Esophageal Squamous Cell Carcinoma In vitro and In vivo
Clin. Cancer Res., February 15, 2006; 12(4): 1308 - 1316.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.